The global antipyretic drug market is anticipated to grow at a CAGR of 2.2% during the forecast period (2023-2030). the growth of the global antipyretic drug market is driven by growing number of bacterial and viral infections globally and also medical treatment costs has seen dramatic growth globally. In january 2023, hyloris announces commercial partnership for maxigesic iv in 9 european countries. It is a unique combination of 1000mg paracetamol with 300mg ibuprofen solution for infusion, thereby reducing both pain and inflammation. Since the pandemic, healthcare has been the greatest driver to our high inflation rates. Healthcare is a basic need where demand is driven by disease growth, which is influenced by new kind of viruses and diseases approaching the world. However, lack of reliability on antipyretic drug in backward and underdeveloped countries considerably hampers the growth of antipyretic drug market. In January 2023, France faced Supply problems with amoxicillin and paracetamol have highlighted reliance on chemicals from China and India. In particular, paracetamol and the common penicillin antibiotic amoxicillin, especially in child doses, are becoming increasingly hard to obtain in pharmacies.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/antipyretic-drug-market
Medical integrates advanced healthcare, treatment, and operation planning, using technology to streamline the product life cycle, in turn, and targeting higher efficiency. For instance, in September 2022, Health officials warned that the start of the autumn Covid wave had begun earlier this week, with early signs of rising cases. The UK Health Security Agency has also warned of a ‘twindemic’ in the coming months, with flu expected to rise as well. Also Ibuprofen and paracetamol are facing a shortage in China at the moment, they are high in demand. India, is ready to step up exports of fever medicines to China as it reels from a spike in COVID-19 cases, the chairperson of an Indian drug export body.
Market Coverage
- The market number available for – 2022-2030
- Base year- 2022
- Forecast period- 2023-2030
- Segment Covered-
o By Type
o By Sale Type
o By Sales Channels
- Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape- includes Sun Pharmaceuticals Industries Ltd., Pfizer Inc., Johnson and Johnson (J&J), Cipla Ltd., and others.
Key Questions Addressed by the Report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Antipyretic Drug Market Report Segment
By Type
- Paracetamol
- Ibuprofen
- Non-Steroidal Anti-Inflammatory Drugs (NSAID)
- Others
By Sales Type
- Prescription (Rx)
- Over the Counter (OTC)
By Sales Channels
- Hospital Pharmacies
- Drug Store and Retail Pharmacies
- Online Pharmacies
- Others (Supermarket)
A full report of Antipyretic Drug Market available @ https://www.omrglobal.com/industry-reports/antipyretic-drug-market
Global Antipyretic Drug Market Report Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- BASF SE
- CIPLA Ltd
- Cumberland Pharmaceuticals
- Divi’s Laboratories Limited
- Reddy’s Laboratories
- Elfin Drugs Private Limited
- Glenmark Pharmaceuticals
- GSK Pharmaceuticals
- Jordanian Pharmaceutical Manufacturing
- LUPIN Limited
- Novartis AG
- NPS MedicineWise
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
